Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Washington
With
National Institute on Drug Abuse (NIDA)
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
age 18-80 years;
CNCP, defined as pain on more than half the days in the past six months, where indicated diagnostic workup is complete and treatment is focused on pain;
currently on COT, defined as self-report of prescribed oral opioid medication use on a daily or near-daily (\>90% of days) basis for 90 days or more;
mean daily opioid dose in the past 30 days of 25 mg MED or greater;
willing to participate in the study arm to which they are randomly assigned (including opioid taper in-person sessions if randomized to that group);
able to read, speak, and write English.
You may not be if
currently receiving treatment for cancer (other than non-melanoma skin cancer);
medical comorbidity with life expectancy less than a year (based on medical record review by the PI);
recent use (past month) of parenteral, transdermal, or transmucosal opioids,
currently residing in nursing home;
currently using intrathecal pump for pain control;
any current substance abuse according to the DSM-IV checklist (nicotine and marijuana will be allowed since Washington State allows medical marijuana for pain control);
presence of illicit drug metabolite in baseline urine drug test,
psychotic symptoms, psychiatric hospitalization or suicide attempts in the past year;
current suicidal ideation with specific plan or intent;
significant cognitive impairment (on 6-item screener Scale).
Clareo Health | Pilot Trial of Opioid Taper Support
